These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24410269)

  • 1. Novel oral suspensions: a review.
    Kathpalia H; Phadke C
    Curr Drug Deliv; 2014; 11(3):338-58. PubMed ID: 24410269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
    Płaczek M; Jacyna J; Sznitowska M
    Pol Merkur Lekarski; 2013 Dec; 35(210):391-6. PubMed ID: 24490472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
    Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.
    Bao Q; Zou Y; Wang Y; Choi S; Burgess DJ
    AAPS J; 2021 Mar; 23(2):42. PubMed ID: 33709196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of enrofloxacin-loaded docosanoic acid solid lipid nanoparticle suspension as oral and intramuscular sustained release formulations for pig.
    Tao Y; Yang F; Meng K; Chen D; Yang Y; Zhou K; Luo W; Qu W; Pan Y; Yuan Z; Xie S
    Drug Deliv; 2019 Dec; 26(1):273-280. PubMed ID: 30880494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropellets coated with Kollicoat
    Dashevskiy A; Mohylyuk V; Ahmed AR; Kolter K; Guth F; Bodmeier R
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1548-1556. PubMed ID: 28478689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
    Oz UC; Devrim B; Bozkır A; Canefe K
    J Microencapsul; 2015; 32(4):317-28. PubMed ID: 26154114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral sustained-release suspension based on a lauryl sulfate salt/complex.
    Kasashima Y; Uchida S; Yoshihara K; Yasuji T; Sako K; Namiki N
    Int J Pharm; 2016 Dec; 515(1-2):677-683. PubMed ID: 27765725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral medication delivery in impaired swallowing: thickening liquid medications for safe swallowing alters dissolution characteristics.
    Manrique YJ; Sparkes AM; Cichero JA; Stokes JR; Nissen LM; Steadman KJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1537-44. PubMed ID: 26857812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical Suspensions: An Updated Patent Review on Novel Suspending Agents and Recent Advancement.
    Kumar P; Verma M
    Recent Adv Drug Deliv Formul; 2023; 17(3):193-209. PubMed ID: 38050417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.
    Chen A; Shi Y; Yan Z; Hao H; Zhang Y; Zhong J; Hou H
    Curr Pharm Des; 2015; 21(29):4355-65. PubMed ID: 26323418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations.
    Visser JC; Ten Seldam IEJ; van der Linden IJ; Hinrichs WLJ; Veenendaal RFH; Dijkers ECF; Woerdenbag HJ
    Int J Pharm Compd; 2018; 22(3):247-251. PubMed ID: 29878892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspensions as a versatile carrier based drug delivery system--an overview.
    Sudhakar B; NagaJyothi K; Murthy KV
    Curr Drug Deliv; 2014; 11(3):299-305. PubMed ID: 24655052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution testing of oral modified-release dosage forms.
    Garbacz G; Klein S
    J Pharm Pharmacol; 2012 Jul; 64(7):944-68. PubMed ID: 22686342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of Natural Polymeric Materials in Solid Oral Modified-Release Dosage Forms.
    Li L; Zhang X; Gu X; Mao S
    Curr Pharm Des; 2015; 21(40):5854-67. PubMed ID: 26446465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating in vitro drug release mechanisms inside dosage forms. Monitoring liquid ingress in HPMC hydrophilic matrices using confocal microscopy.
    Melia CD; Marshall P; Stark P; Cunningham S; Kinahan A; Devane J
    Adv Exp Med Biol; 1997; 423():129-35. PubMed ID: 9269488
    [No Abstract]   [Full Text] [Related]  

  • 20. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.
    Aleksovski A; Dreu R; Gašperlin M; Planinšek O
    Expert Opin Drug Deliv; 2015 Jan; 12(1):65-84. PubMed ID: 25200881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.